Novel combinational therapies: Is the increased toxicity worth the possibility of increased benefit?

Novel combinational therapies: Is the increased toxicity worth the possibility of increased benefit?

User Photo
kidneycancer

2 years
57 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Chung-Han (Joe) Lee, MD/PhD Memorial Sloan Kettering Cancer Center discusses Novel combinational therapies: Is the increased toxicity worth the possibility of increased benefit? at the Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL September 22, 2018
Up Next Autoplay
>